M&A Deal Summary |
|
|---|---|
| Date | 2010-04-29 |
| Target | ATS Medical |
| Sector | Medical Products |
| Buyer(s) | Medtronic |
| Sellers(s) |
EW Healthcare Partners
Alta Partners |
| Deal Type | Add-on Acquisition |
| Deal Value | 370M USD |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1949 |
| Sector | Medical Products |
| Employees | 95,000 |
| Revenue | 32.4B USD (2024) |
Medtronic is a global medical technology company whose products aim to alleviate pain, restore health, and extend life. It serves hospitals, physicians, clinicians, and patients in approximately 160 countries worldwide. Medtronic was founded in 1949 and is based in Dublin, Ireland with its operational headquarters in Fridley, Minnesota.
| DEAL STATS | # |
|---|---|
| Overall | 23 of 59 |
| Sector (Medical Products) | 22 of 52 |
| Type (Add-on Acquisition) | 23 of 57 |
| State (Minnesota) | 5 of 6 |
| Country (United States) | 20 of 44 |
| Year (2010) | 2 of 3 |
| Size (of disclosed) | 14 of 36 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-01-25 |
Invatec
Bethlehem, Pennsylvania, United States Invatec is an innovator in the development and commercialization of interventional coronary and peripheral products, with global headquarters in Europe. Driven by research and technology, Invatec actively collaborates with physicians and centers of excellence to develop products that will improve life expectancy and quality of life for patients. |
Buy | $500M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-11-16 |
Osteotech
Eatontown, New Jersey, United States Osteotech, Inc. is a provider of biologic solutions for regenerative medicine to support surgeons and their patients in the repair of the musculoskeletal system through the development of innovative therapy-driven products that alleviate pain, promote biologic healing and restore function. Osteotech was formed in 1986 and is based in Eatontown, New Jersey. |
Buy | $123M |
| Category | Growth Capital Firm |
|---|---|
| Founded | 1985 |
| PE ASSETS | 3.0B USD |
| Size | Large |
| Type | Sector Focused |
Essex Woodlands Health Ventures is a growth equity and venture capital specialist investment firm focused on opportunities across the healthcare sector. Specific areas of interest include biotechnology, pharmaceuticals, medical devices, and healthcare services/IT. Historically, Essex invested primarily in early and later-stage situations; however, today the firm also makes growth capital investments between $20 - $60 million in companies valued between $50 - $250 million, as well as private investments in public entities (PIPEs). Essex Woodlands was formed in 1985 and offices in Palo Alto, California; New York City; Houston, Texas; Shanghai and London.
| DEAL STATS | # |
|---|---|
| Overall | 19 of 53 |
| Sector (Medical Products) | 9 of 24 |
| Type (Add-on Acquisition) | 12 of 34 |
| State (Minnesota) | 1 of 2 |
| Country (United States) | 17 of 46 |
| Year (2010) | 4 of 7 |
| Size (of disclosed) | 5 of 22 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-04-06 |
Ception Therapeutics
Malvern, Pennsylvania, United States Ception Therapeutics, Inc. is a emerging biopharmaceutical company which develops novel products to address unmet medical needs. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-05-05 |
TearScience
Morrisville, North Carolina, United States TearScience is a medical device manufacturer dedicated to evaluating meibomian gland health and treating meibomian gland dysfunction (MGD). TearScience was founded in 2005 and is based in Morrisville, North Carolina. |
Buy | - |
| Category | Venture Capital Firm |
|---|---|
| Founded | 1996 |
| PE ASSETS | 2.6B USD |
| Size | Large |
| Type | Sector Focused |
Alta Partners is a venture capital firm that targets investments in early and later stage life science companies, including biopharmaceuticals, medical technology, and information technology businesses. Alta was formed as an early stage investor but has since expanded its investment range to provide later stage growth capital to private and young public companies. Alta was established in 1996 and is headquartered in San Francisco, California.
| DEAL STATS | # |
|---|---|
| Overall | 43 of 84 |
| Sector (Medical Products) | 6 of 8 |
| Type (Add-on Acquisition) | 29 of 45 |
| State (Minnesota) | 4 of 4 |
| Country (United States) | 36 of 74 |
| Year (2010) | 2 of 5 |
| Size (of disclosed) | 11 of 23 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-04-07 |
Achaogen
San Francisco, California, United States Achaogen is a bio-pharmaceutical company developing treatments for life-threatening infections caused by multi-drug resistant (MDR) Gram-negative bacteria, an area of critical unmet medical need. Achaogen was formed in 2002 and is based in San Francisco, California. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-05-03 |
Ellie Mae
Pleasanton, California, United States Ellie Mae automates and digitizes the trillion-dollar residential mortgage industry. Through its Digital Lending Platform, Ellie Mae provides technology services to all participants in the mortgage supply chain, including its over 3,000 customers and thousands of partners and investors participating in the open networks who provide liquidity to the market. Lenders rely on Ellie Mae to securely manage and facilitate the exchange of data across the ecosystem to enable the origination of mortgages while maintaining strict adherence to various local, state, and federal compliance requirements. Ellie Mae was formed in 1997 and is based in Pleasanton, California. |
Buy | - |
